Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Verastem
VSTM
$604M
| $723K | ﹤0.01% |
38,120
+31,041
| +438% | +$498K |
|
|
PPIH
2727
Perma-Pipe International
PPIH
$216M
| $718K | ﹤0.01% |
102,600
+14,400
| +16% | +$101K |
|
|
OSIR
2728
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $717K | ﹤0.01% |
125,641
-46,066
| -27% | -$322K |
|
|
HMNF
2729
DELISTED
HMN Financial Inc
HMNF
| $714K | ﹤0.01% |
63,400
+2,300
| +4% | +$26K |
|
2730
Triumph Financial Inc
TFIN
$1.87B
| $712K | ﹤0.01% |
45,000
+5,300
| +13% | +$76.1K |
|
2731
Eagle Materials
EXP
$6.47B
| $708K | ﹤0.01% |
+10,100
| New | +$588K |
|
|
PES
2732
DELISTED
Pioneer Energy Services Corp.
PES
| $707K | ﹤0.01% |
321,298
-182,522
| -36% | -$301K |
|
2733
Regional Management Corp
RM
$297M
| $702K | ﹤0.01% |
41,000
-25,500
| -38% | -$373K |
|
|
CCR
2734
DELISTED
CONSOL Coal Resources LP
CCR
| $698K | ﹤0.01% |
+97,201
| New | +$681K |
|
|
SCS
2735
DELISTED
Steelcase
SCS
| $695K | ﹤0.01% |
+46,600
| New | +$620K |
|
|
BSTG
2736
DELISTED
Biostage, Inc. Common Stock
BSTG
| $690K | ﹤0.01% |
385,400
-8,400
| -2% | -$13.9K |
|
2737
New Jersey Resources
NJR
$5.64B
| $689K | ﹤0.01% |
18,900
-51,100
| -73% | -$1.77M |
|
|
ZGNX
2738
DELISTED
Zogenix, Inc.
ZGNX
| $685K | ﹤0.01% |
74,087
-62,800
| -46% | -$629K |
|
2739
Landmark Bancorp
LARK
$197M
| $683K | ﹤0.01% |
44,480
+5,212
| +13% | +$79.1K |
|
|
IEC
2740
DELISTED
IEC Electronics Corp.
IEC
| $681K | ﹤0.01% |
151,400
+78,800
| +109% | +$301K |
|
2741
iShares China Large-Cap ETF
FXI
$4.16B
| $679K | ﹤0.01% |
20,100
+7,000
| +53% | +$220K |
|
|
CNBKA
2742
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $677K | ﹤0.01% |
17,400
+3,400
| +24% | +$136K |
|
2743
HCI Group
HCI
$2.28B
| $676K | ﹤0.01% |
20,300
-36,000
| -64% | -$1.17M |
|
2744
Freshpet
FRPT
$3.48B
| $671K | ﹤0.01% |
+91,500
| New | +$638K |
|
|
MDC
2745
DELISTED
M.D.C. Holdings, Inc.
MDC
| $669K | ﹤0.01% |
+37,082
| New | +$598K |
|
|
ONVI
2746
DELISTED
Onvia, Inc.
ONVI
| $669K | ﹤0.01% |
191,000
+4,800
| +3% | +$17.4K |
|
|
AIOT
2747
PowerFleet Inc
AIOT
$421M
| $667K | ﹤0.01% |
153,715
-1,500
| -1% | -$6.36K |
|
|
KTEC
2748
DELISTED
Key Technology Inc
KTEC
| $667K | ﹤0.01% |
97,800
+10,300
| +12% | +$76.7K |
|
|
GOL
2749
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $660K | ﹤0.01% |
438,200
+237,500
| +118% | +$273K |
|
2750
Aspen Aerogels
ASPN
$504M
| $659K | ﹤0.01% |
146,500
+18,400
| +14% | +$83.4K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.